trending Market Intelligence /marketintelligence/en/news-insights/trending/a1mifygiov9teial9m2vwa2 content esgSubNav
In This List

ReShape plans reverse stock split to regain Nasdaq compliance

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


ReShape plans reverse stock split to regain Nasdaq compliance

ReShape Lifesciences Inc. said it received a noncompliance notice from Nasdaq for failing to meet the minimum bid price requirement.

The closing bid price of the San Clemente, Calif.-based medical device maker's listed securities failed to reach the minimum $1.00 per share for the past 30 consecutive business days.

ReShape has 180 days to regain compliance, and intends to propose a reverse stock split at a ratio between 1-for-8 and 1-for-15 at its May 23 annual meeting.

ReShare develops devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.